Clearside Biomedical, Inc. Quarterly Operating Income (Loss) in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Clearside Biomedical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2015 to Q3 2024.
  • Clearside Biomedical, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.93M, a 15.9% increase year-over-year.
  • Clearside Biomedical, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24.6M, a 17.8% increase year-over-year.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2023 was -$24.8M, a 17.9% increase from 2022.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2022 was -$30.3M, a 4729% decline from 2021.
  • Clearside Biomedical, Inc. annual Operating Income (Loss) for 2021 was -$627K, a 96.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$24.6M -$5.93M +$1.12M +15.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$25.8M -$7.59M -$320K -4.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$25.4M -$8.21M -$604K -7.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$24.8M -$2.92M +$5.16M +63.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$30M -$7.05M -$330K -4.91% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$29.7M -$7.27M +$567K +7.24% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$30.2M -$7.61M +$41K +0.54% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$30.3M -$8.07M -$26.8M -143% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$3.5M -$6.72M -$1.84M -37.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.67M -$7.84M -$1.74M -28.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $76K -$7.65M +$703K +8.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$627K $18.7M +$25.8M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 -$26.4M -$4.89M -$2.46M -101% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$24M -$6.1M -$539K -9.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$23.4M -$8.35M -$5.51M -194% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$17.9M -$7.11M -$4.1M -136% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 -$13.8M -$2.43M +$3.94M +61.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$17.8M -$5.56M +$60K +1.07% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$17.8M -$2.84M +$12.5M +81.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$30.3M -$3.01M +$18.6M +86.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 -$48.9M -$6.37M +$17.6M +73.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$66.5M -$5.62M +$15.3M +73.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$81.8M -$15.3M +$1.15M +6.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$82.9M -$21.6M -$5.31M -32.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 -$77.6M -$24M -$5.76M -31.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$71.9M -$20.9M -$7.27M -53.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$64.6M -$16.5M -$6.2M -60.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$58.4M -$16.3M -$6.96M -74.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q3 2017 -$51.4M -$18.2M -$12.9M -243% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$38.6M -$13.6M -$8.46M -163% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$30.1M -$10.3M -$4.9M -91.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$25.2M -$9.36M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 -$5.31M -$1.93M -57.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$5.18M -$8K -0.16% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$5.36M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 -$3.37M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$5.17M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.